1. International Conference on Harmonization. ICH topic E10—Choice of control group in clinical trials. Note for guidance on choice of control group in clinical trials. (CPMP/ICH/364/96). London, UK: European Agency for the Evaluation of Medicinal Products; July 27, 2000.
2. World Medical Association. Declaration of Helsinki—Ethical Principles for Medical Research Involving Human Subjects, revision of the 52nd WMA General Assembly. Edinburgh, Scotland: World Medical Association; October 2000.
3. Committee for Proprietary Medicinal Products. Points to Consider The choice of delta in non-inferiority studies.http://www.emea.eu.int/pdfs/human/ewp/215899en.pdf.
4. Temple R, Ellenberg S. Placebo-controlled trials and active-controlled trials in the evaluation of new treatments, Part 1: Ethical and scientific issues. Ann Intern Med., 2000;133:455–463.
5. Ellenberg S, Temple R. Placebo-controlled trials and active-controlled trials in the evaluation of new treatments, Part 2: Practical issues and specific cases issues. Ann Intern Med., 2000;133:464–470.